JACOBS IAN SETH enters LOMOND THERAPEUTICS HOLDINGS, INC. with 250K shares — 100% direct ownership
Full direct ownership at entry is the strongest form of insider alignment with shareholders.
Direct
Filed: 2/10/2022ACC: 0001213900-22-006620
DirectorOfficer10% Owner· President, CEO, CFO, Secretary
Since Feb 2022
250K
Baseline shares
100% direct
250K
Direct ownership
1 position
0.00
Derivative underlying
0 instruments
1
Security positions
All direct
Non-Derivative Holdings1
Common Stock
DirectShares owned250K
Total
250K direct250K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 250K | Direct |
| Total | 250K | 250K direct |
Derivative Holdings0
No derivative holdings reported